The product is a highly efficient, inducible WT Cas9-ACCN2 gene-editing based novel AAV packaging system that can be used to mediate researches involving anti-MMP14 mab (M03I1Q-C0J8V) in Murine B cell engineering.
| Clone | M03I1Q-C0J8V |
| Host | Human |
| Packaging Cell Line | CHO |
| Vector Promoter | EF1a |
| Rep | Rep68 |
| Capsid | P24 |
| Envelope | Env |
| Matrix | C-terminal |
| Size | ~30kb |
| Genome | dsDNA |
| Virus Type | AAV |
| Cofactor Requirement | No ATP, CP, or CPK |
| Particles/mL | 2.6 × 10¹¹ |
| PFU/mL | 5.1 × 10¹¹ |
| TU/mL | 8.3 × 10¹¹ |
| Cas9 | WT Cas9 |
| sgRNA | ACCN2 |
| Engineered B Cell | Murine B cells |
| Target | MMP14 |
| Alternative Names | MMP14; MMP-14; MMP-X1; MT-MMP; MT-MMP 1; MT1-MMP; MT1MMP; MTMMP1; WNCHRS; matrix metallopeptidase 14 |
| Format | Liquid |
| Shipping | The product is shipped by dry ice. |
| Storage | Upon receipt, store immediately at -80°C or lower for long-term storage. Avoid freeze/thaw cycles. |
Certificate of Analysis Lookup
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.